Actively Recruiting Studies and Clinical Trials
Our Center supports a wide variety of Alzheimer’s disease-related research. If you are interested in participating in one of our studies, please call (617) 358-5382 or email joinADC@bu.edu for more information.
Although there may not be a study for you right now, there may be a study for you in the future. Please still give us a call so we can keep you up to date on future studies.
Alzheimer’s Disease Neuroimaging Initiative 3
ADNI 3 aims to determine the relationships between the clinical, cognitive, imaging, genetic and biochemical biomarker characteristics of the entire spectrum of Alzheimer’s disease (AD).
Eligibility: Are between the ages of 55-90 and are Healthy Aduls or individuals with MCI or AD.
REVEAL-SCAN is an NIH-funded, multisite clinical trial that will explore the impact of learning amyloid imaging results among asymptomatic older adults, and how to safely communicate these results and educate on the risk of developing Alzheimer’s disease (AD).
Eligibility: Are between the ages of 65-80 and are a healthy adult
Detection and Diagnosis
Health Outreach Program for the Elderly (HOPE)
The HOPE study is the BU ADC main registry of participants. People who join HOPE attend a yearly visit in which their memory and thinking abilities are evaluated. They also participate in other BU ADC affiliated studies.
Eligibility: Healthy adults, MCI, AD
Feasibility of using physical activity monitoring for enhancing cognition in healthy seniors
The goal of this study is to examine whether digital self-monitoring of physical activity, with the goal to reach at least 150 minutes of moderate-intensity physical activity per week over a 12-week period, can improve cognition and functional fitness comparable to an aerobic exercise program of the same duration in initially physically inactive healthy seniors.
Eligibility: Are between the ages of 55-85
The Light Study
This study is looking at detect changes in the brain associated with aging and cognitive impairment using near infrared spectroscopy (NIRS).
Eligibility: Are between ages 65-85 years old and are a healthy adult, or diagnosed with MCI or AD
Subclinical Paroxysmal EEG Abnormalities in Alzheimer’s Disease
The purpose of this research study is to find out if patients with early Alzheimer’s disease have periods of abnormal brain activity, such as seizures, that might explain some of their memory problems.
Eligibility: Are between the ages of 50-90 and are a healthy adult,or diagnosed with MCI or Lewey Body Dementia
Near Infrared Spectroscopy and Electroencephalography of Brain Function
This study is designed to research a new system designed to measure brain activity by taking a series of measurements while a variety of tasks are performed.
Eligibility: Are between 65 and 74 and who are healthy individuals or individuals diagnosed with MCI.
This study looks at participant responses to certain cognitive testing. Research suggests that patients with different types of brain problems perform differently on certain tests. The goal of this study is to better understand how different brain problems affect perception, thinking and memory, hopefully leading to better diagnostic evaluations.
Eligibility: Are between 65-90 years old who are healthy adults or diagnosed with MCI or AD.
Alzheimer’s Association National Chapter
Alzheimer’s Association MA/NH Chapter
National Institute on Aging’s Alzheimer’s Disease Education and Referral Center
Boston Medical Center Memory Disorder’s Clinic